{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-030540","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.342612+00:00","generated_at":"2026-05-31T11:43:18.435659+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Propanc Biopharma enters $150K AUD loan agreement with 12% interest, due Nov 2024","bullets":["Loan of $150,000 AUD effective Aug 1, 2024, with maturity Nov 1, 2024.","Interest rate 12% per annum; prepayable at any time without penalty.","Proceeds will be used for general working capital purposes.","Loan issued under private placement exemption per Section 4(a)(2) and Rule 506."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-030540","json":"https://secwatch.observer/filing/0001493152-24-030540.json","markdown":"https://secwatch.observer/filing/0001493152-24-030540.md","text":"https://secwatch.observer/filing/0001493152-24-030540.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224030540/0001493152-24-030540-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224030540/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:43:18.435659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}